Guoxiong Zhou

Dr. Guoxiong Zhou


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2024 in Phytomedicine
Verified
Journal Article
Open access
YRYun Ruan
Yun Ruan
XZXiaolin Zhu
Xiaolin Zhu
JSJianbo Shen
Jianbo Shen
HCHao Chen
Hao Chen
GZGuoxiong Zhou
Guoxiong Zhou
The incidence of ulcerative colitis (UC) is on the rise globally and the development of drugs targeting UC is urgent. Finding the target of action of natural products is important for drug discovery, elucidation of drug action mechanism, and disease mechanism. San-Ye-Qing (SYQ), is an ancient herbal medicine, but whether the powder of its rhizome has pharmacological effects against UC and its mechanism of action are not clear. To evaluate the therapeutic effectiveness of rhizome powder of SYQ in treating UC, and conduct an isolation and characterization of the chemical constituents of the powder. Further, screen the most potent compounds among them and determine the potential mechanism for treating UC. In vivo, the therapeutic effect of SYQ's rhizome powder on UC was assessed by mice's body weight, DAI score, colon length, tissue MPO activity, serum inflammatory markers, etc. Additionally, HPLC was used to isolate and identify the specific chemical components of SYQ's rhizome powder. Then, the most effective compounds and their therapeutic targets were analysed and screened in SYQ rhizome powder using network pharmacology, combined with CCK-8 assay, NO release assay and molecular docking assay, in conjunction with CETSA, DARTS, SPR and enzyme activity assay. Finally, the biological effects of the key compound on the targets were validated using Western blot and ELISA. In vivo, SYQ rhizome powder effectively restored mice's body weight, lowered DAI and pathological score, downregulated the expression of inflammatory biomarkers, and restored colon length, as well as the colonic epithelial and mucus barriers. Afterward, 9 compounds were isolated and identified from the powder of the rhizomes of SYQ by HPLC. Nicotiflorin is the primary compound in SYQ with the highest concentration. According to both CCK-8 and NO release tests, Nicotiflorin is also the most efficacious compound. Combined with network pharmacological prediction, molecular docking analysis, CETSA, DARTS, SPR and enzyme activity assay, Nicotiflorin may ultimately suppress inflammation by targeting p65 and inhibiting the NF-κB pathway, thereby attenuating the activation of NLRP3 inflammasome. To verify this conclusion, Western blot and ELISA experiments were conducted. Our results suggest that the extract from SYQ rhizomes has therapeutic properties for UC. Its active ingredient Nicotiflorin exerted potent anti-UC effects by binding to p65 and inhibiting the activation of NF-κB and NLRP3 inflammasomes.

7 December 2022 in Pharmacological Research
Verified
Journal Article
Open access
HHHexu Han
Hexu Han
TLTing Lin
Ting Lin
ZWZhenyu Wang
Zhenyu Wang
JSJingjing Song
Jingjing Song
ZFZiyi Fang
Ziyi Fang
GZGuoxiong Zhou
Guoxiong Zhou
Increased angiogenesis in the liver plays a critical role in the progression of hepatocellular carcinoma (HCC). However, the molecular mechanism underlying increased angiogenesis in HCC is not well understood. Current study was designed to identify the potential angiogenic effect of RNA-binding motif 4 (RBM4)through a small-scale overexpression screening, followed by comparison of the expression level of RBM4 in cancer and adjacent tissues in multiple malignancies to explore the relationship between RBM4 and CD31 protein expression level and related clinical indicators, and understand the role of RBM4 in the hepatocellular carcinoma. To understand the specific mechanism of RBM4 in detail, transcriptome sequencing, mass spectrometry and multiple molecular cytological studies were performed. These cellular level results were verified by experiments in animal models of nude mice. The increased expression of RBM4 in cancer tissues, suggested its use as a prognostic biomarker. The RBM4 expression was found to be strongly correlated with tumor microvessel density. Mechanistically, RBM4 mediated its effects via interaction with HNRNP-M through the latter's WDR15 domain, which then stabilized RelA/p65 mRNA. Consequently, RBM4 induced the activation of the NF-kB signaling pathway, upregulating the expression of proangiogenic factor VEGF-A. The results confirmed the mechanism by which RBM4 promotes angiogenesis in hepatocellular carcinoma suggesting RBM4 as a crucial promoter of angiogenesis in HCC, helping understand regulation of NF-kB signaling in HCC.

5 December 2014 in Oncology Reports
Verified
Journal Article
Open access
PDF file
GZGuoxiong Zhou
Guoxiong Zhou
XDXiao-Ling Ding
Xiao-Ling Ding
SWSheng-Bao Wu
Sheng-Bao Wu
HZHai-Feng Zhang
Hai-Feng Zhang
WCWei Cao
Wei Cao
HZHong Zhang
Hong Zhang
The 5-lipoxygenase (5-LOX) pathway has been associated with a variety of inflammatory diseases including asthma, atherosclerosis, rheumatoid arthritis, cancer and liver fibrosis. Several classes of 5-LOX inhibitors have been identified, but only one drug, zileuton, a redox inhibitor of 5-LOX, has been approved for clinical use. In the present study, 5-LOX was found to be overexpressed not only in pancreatic cancer cell lines but also in tissue samples of patients suffering from pancreatic adenocarcinoma. There was a close correlation between the tumor expression levels of 5-LOX mRNA and protein and the clinicopathological patient characteristics including lymph node metastasis and TNM stage. Zileuton suppressed the proliferation of SW1990 cells in a concentration- and time‑dependent manner. In addition, zileuton induced SW1990 cells to undergo apoptosis and significantly decreased 5-LOX expression. The number of apoptotic cells, estimated by flow cytometry, Annexin V/PI assay, TUNEL staining and sub‑diploid population was significantly higher than that of the control. These results suggest that the level of 5-LOX expression was increased in pancreatic cancer tissues and may be related to lymph node metastasis and TNM stage.

1 April 2016 in Cancer Letters
Verified
Journal Article
Closed access
CWChunhua Wan
Chunhua Wan
CGChen Gong
Chen Gong
HZHaifeng Zhang
Haifeng Zhang
LHLu Hua
Lu Hua
XLXiaohong Li
Xiaohong Li
ASAiguo Shen
Aiguo Shen

28 May 2020 in Investigational New Drugs
Verified
Journal Article
Closed access
PDF file
HCHao Chen
Hao Chen
XZXiaoling Zhu
Xiaoling Zhu
RSRong Sun
Rong Sun
PMPanpan Ma
Panpan Ma
EZErhao Zhang
Erhao Zhang
RMRenfang Mao
Renfang Mao

15 August 2015 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
CWChunhua Wan
Chunhua Wan
CGChen Gong
Chen Gong
LJLi Ji
Li Ji
XLXiaorong Liu
Xiaorong Liu
YWYayun Wang
Yayun Wang
YZYixin Zhang
Yixin Zhang